0001591698-23-000017.txt : 20230215 0001591698-23-000017.hdr.sgml : 20230215 20230215162201 ACCESSION NUMBER: 0001591698-23-000017 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230203 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beauchamp Steven R CENTRAL INDEX KEY: 0001314830 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36348 FILM NUMBER: 23635652 MAIL ADDRESS: STREET 1: 3850 N. WILKE ROAD CITY: ARLINGTON HEIGHTS STATE: IL ZIP: 60004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paylocity Holding Corp CENTRAL INDEX KEY: 0001591698 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 464066644 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1400 AMERICAN LANE CITY: SCHAUMBURG STATE: IL ZIP: 60173 BUSINESS PHONE: 800-520-2687 MAIL ADDRESS: STREET 1: 1400 AMERICAN LANE CITY: SCHAUMBURG STATE: IL ZIP: 60173 4/A 1 wf-form4a_167649610352861.xml FORM 4/A X0306 4/A 2023-02-03 2023-02-07 0 0001591698 Paylocity Holding Corp PCTY 0001314830 Beauchamp Steven R C/O 1400 AMERICAN LANE SCHAUMBURG IL 60173 1 1 0 0 Co-Chief Executive Officer Common Stock, par value $0.001 2023-02-03 4 M 0 1950 17 A 1757036 D Common Stock, par value $0.001 2023-02-03 4 F 0 695 235 D 1756341 D Common Stock, par value $0.001 2023-02-03 4 S 0 1255 235 D 1755086 D Common Stock, par value $0.001 220000 I by IRIE Family Trust Common Stock, par value $0.001 22500 I by IRIE Foundation Non-Qualified Stock Option (right to buy) 17.0 2023-02-03 4 M 0 1950 0 A 2015-03-24 2024-03-18 Common Stock, par value $0.001 1950.0 14716 D This amendment is being filed to correct the shares reported in the Form 4 filed on February 7, 2023 with respect to the amount of non-qualified stock options exercised, to correct the amount of shares withheld for the reporting person's tax and exercise price obligations upon the exercise of non-qualified stock options and to correct the total amount of derivative securities beneficially owned following the reported transaction. The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on November 17, 2022. /s/ Kris Kang, attorney-in-fact to Steven R. Beauchamp 2023-02-15